Error: Could not add to watchlist. X

APO Medical Opportunities

+ Watchlist
APOMOPP:LX
130.52
EUR
1.00
0.77%
As of 00:59:30 ET on 07/01/2015.
Volume
0
Previous Close
129.52
52Wk Range
103.45 - 133.75
1 Yr Return
20.42%
Fund Type
-
Objective
-
Asset Class Focus
-
Geographic Focus
-
NAV (on 07/01/2015)
130.52
Total Assets (m EUR) (on 07/01/2015)
214.101
Inception Date
08/31/2005
Last Dividend (on 12/31/2013)
-
Dividend Indicated Gross Yield
-
Fund Managers
KAI BRUENING / HARALD SCHWARZ
Front Load Fee
5.00%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
0.57%
Expense Ratio
1.96%
Top Fund Holdings
Name Position Value % of Fund
Novartis AG 62.65 k 5.76 m 3.05
Bayer AG 34.52 k 4.45 m 2.36
Pfizer Inc 145.26 k 4.36 m 2.31
Amgen Inc 31.11 k 4.36 m 2.31
GlaxoSmithKline PLC 187.43 k 3.83 m 2.03
Roche Holding AG 13.71 k 3.51 m 1.86
BioMarin Pharmaceutical Inc 34.37 k 3.43 m 1.82
Abbott Laboratories 81.60 k 3.38 m 1.79
Sanofi 37.59 k 3.32 m 1.76
H Lundbeck A/S 177.46 k 3.08 m 1.63
Profile
APO Medical Opportunities is an open-end investment fund incorporated in Luxembourg. The Fund's objective is long-term capital appreciation. The Fund invests primarily in equities of companies from the health care sector.
ADDRESS
IPConcept (Luxemburg) S.A.
4, rue Thomas Edison
L-1445 Luxembourg-Strassen
Luxembourg
PHONE
352-260248-1 Tel